...
机译:N-(环烷基氨基)酰基-2-氨基噻唑细胞周期蛋白依赖性激酶2抑制剂。N-5-5-(1,1-二甲基乙基)-2-恶唑基甲基硫基-2-噻唑基-4-哌啶甲酰胺(BMS-387032),一种高效和选择性的抗肿瘤药物
Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, New Jersey 08543-4000;
Lexicon Pharmaceuticals, 350 Carter Rd., Princeton, NJ 08540;
Astra-Zeneca R&D Boston, 35 Gatehouse Dr., Waltham, MA 02451;
机译:细胞周期蛋白依赖性激酶2的N-(环烷基氨基)酰基-2-氨基噻唑抑制剂。N-[5-[[[[5-(1,1-二甲基乙基)-2-恶唑基]甲基]硫代] -2-噻唑基]- 4-哌啶甲酰胺(BMS-387032),一种高效,选择性的抗肿瘤药物
机译:Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies
机译:Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease